Arrowhead Pharmaceuticals, Inc. today announced interim results from two Phase 1/2a clinical trials of ARO-INHBE and ARO-ALK7, the company's investigational RNA interference (RNAi) therapeutics being ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Transverse tubules (T-tubules) play significant role in muscle contraction. However, the underlying mechanism of their ...

Silexion Therapeutics ( ($SLXN) ) has shared an announcement. On January 6, 2026, Silexion Therapeutics released a CEO letter to shareholders ...

Linkage Global Inc. announced at the 2026 Consumer Electronics Show (CES) that it has entered strategic intellectual property partnerships with premium headphone brand ClickClack and VIBELENS. Under ...

Detailed price information for Silence Therapeutics Plc ADR (SLN-Q) from The Globe and Mail including charting and trades.

With a new year just days away, we hope the following list of the top 10 patents of 2025 sparks interest in the state of ...

ALMA in Chile receives 145 low-noise amplifiers for Band 2, enabling detailed studies of cold interstellar gas, planet-forming disks, and organic molecules in nearby galaxies.

Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA ...

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA ...

Pancreatic ductal adenocarcinoma (PDAC) is the most lethal form of pancreas cancer. It's also the most common form of the ...